Market Research Logo

Nigeria Pharmaceuticals and Healthcare Report Q2 2016

Nigeria Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Nigeria's prospects of attaining national health coverage will largely depend upon the successof the National Health Act. This, however, will continue to face a number of challenges that have previouslyled to delays in its implementation. The eventual rollout of the act will make Nigeria an attractive prospectfor multinational drugmakers over the long-term, though political and fiscal barriers limit the successfullikelihood of its implementation and subsequent investment opportunities.

Headline Expenditure Projections

Pharmaceuticals: NGN175.90bn (USD891mn) in 2015 to NGN187.33bn (USD905mn) in 2016; +6.5%in local currency terms and +1.6% in US dollar terms. Forecast revised upwards from last quarter.

Healthcare: NGN3.97trn (USD20.08bn) in 2015 to NGN4.43trn (USD21.41bn) in 2016; +11.7% inlocal currency terms and +6.6% in US dollar terms. Forecast revised upwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Nigeria 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Nigeria 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Nigeria 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Nigeria 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Nigeria 2014-2020)
Industry Risk Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Nigeria Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Nigeria 2010-2015)
Table: Healthcare Personnel (Nigeria 2010-2015)
Table: Healthcare Activity (Nigeria 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution & Retail Sector
Company Profile
GlaxoSmithKline
Fidson Healthcare
May & Baker
Merck & Co
Neimeth Pharmaceuticals
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Nigeria 1990-2025)
Table: Key Population Ratios (Nigeria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Nigeria 1990-2025)
Table: Population By Age Group (Nigeria 1990-2025)
Table: Population By Age Group % (Nigeria 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report